Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effect of Ringerfundin B. Braun vs Plasma-Lyte Baxter in Healthy Volunteers
2005-003350-99Phase 4Completed
- Sponsor
- B. Braun
- Start
- Aug 2005
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Ringerfundin (2 arms), sponsored by B. Braun. Primary endpoints: Primary completion and Basal metabolism change. Started Aug 2005; status: completed.
02
Drugs
Ringerfundin
Beyond the preview
Go deeper on 2005-003350-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003350-99.